UPDATE: Cantor Fitzgerald Starts Oramed Pharma (ORMP) at Overweight
Tweet Send to a Friend
(Updated - February 18, 2022 6:34 AM EST)
Cantor Fitzgerald analyst Charles C. Duncan initiates coverage on Oramed Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Cantor Fitzgerald analyst Charles C. Duncan initiates coverage on Oramed Pharma ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


